首页> Journal of Medical Genetics> Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing.

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing.

导出原文传递

翻译打印收藏纠错

第一作者： Evans DG

作者： Evans DG ^[1] ; Lalloo F ; Cramer

作者单位： University of Manchester, Central Manchester Foundation Hospital NHS Trust, St Mary's Hospital, Manchester, UK. ^[1]

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Medical Genetics

2009年46卷12期

811-817页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Journal of Medical Genetics

2009年46卷12期

811-817页

检索历史清除

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing.

Journal of Medical Genetics

相似文献

同项目论文

Journal of Medical Genetics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing.

Journal of Medical Genetics

相似文献

同项目论文

Journal of Medical Genetics

相关期刊

检索历史清除